This page shows the latest market landscape news and features for those working in and with pharma, biotech and healthcare.
Without doubt, the nature of the work we do. The market landscape in which we work has changed dramatically over this time which in turn has profoundly shaped both what we
A recent comprehensive European analysis confirms a poor correlation between market share and price. ... Preparation will be key to understanding the many complex factors that influence the adoption of biosimilars and, critically, to building an accurate
CUP helps facilitate a smoother transition of orphan drugs from clinical trials to market, and also helps companies as they develop global launch strategies for global usage patterns and market landscape ... predictions. In addition, market authorisation
Starting a patient support project with a synthesis of the market landscape that includes relevant input from key internal stakeholders will help align the team from the outset. ... They are thought through, grounded in real market insight and built on a
"Clearer, faster decision-making" promised. The recent unveiling of the new Cancer Drugs Fund (CDF) in the UK marked a major shift in the market access landscape, but it's one
An ever-closer union? Surveying Europe's market access landscape, the trend for cross-border collaboration looks set to continue, but there are significant changes ahead as some of the ... Germany prepares for significant change. Notwithstanding growing
More from news
Approximately 0 fully matching, plus 22 partially matching documents found.
Our reliance on artificial intelligence is reflected in the technology’s growing dominance in the financial landscape: the global AI in healthcare market size is projected to grow from $4.9bn
With the rapidly evolving market access landscape, we are now on the cusp of a huge acceleration in the use of digital applications to explore value options, gain strategic advantage and ... New cloud technology provides an improved framework for
But are these traditionally linear models enough in an ever-evolving healthcare market landscape that is being so radically transformed in the digital age? ... Adding value. Within the pharmaceutical industry today, companies are re-orientating to a more
a successful market assessment strategy. ... It will look at how marketers can understand the competitive market landscape as early as possible.
In Germany, there are regional and local regulations in addition to the centralised market access regulations. ... This needs to be factored in as early as possible during the drug development pipeline, starting with close analysis of the local and
More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.
She is joined at the market research company by fellow new recruit Paul O'Meara, who has been appointed regional head of syndicated studies. ... In addition, van Kemenade has experience in market landscape, target product profiling, patient record studies
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Monitoring the impact of COVID-19 on the market access landscape. Register now for Research Partnership's next live webinar in which their specialist market access team will share insights from ... their COVID-19 impact study and advise how
This involves planning activities like a situation analysis to understand the treatment landscape, market-shaping, awareness campaigns, development of a brand launch strategy, brand messaging, and customer-facing tactics. ... Today, it is more common to
In a Valid Insight webinar, we brought together key stakeholders to discuss the global coronavirus (COVID-19) pandemic and its effects on pharmaceutical pricing and market access. ... Preparing for a post-COVID-19 future in market access, including how
However, for pharmaceutical companies this means increased competition in an already crowded market place, making the launch landscape far more complex. ... This includes pivoting to keep up with market fluctuations and anticipating the competition.
I am witnessing a growing appreciation of new technology as a strategic asset within market access. ... Our tailored services include a suite of digital applications that transform market access processes.
More from PMHub
Approximately 1 fully matching, plus 19 partially matching documents found.
OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...